How it all began - from the writing of the 'Biomarkers' work package to the challenges of the Investigator Training Meetings
Standard operating proceduers I. - 'Standard Operating Procedures for sample handling'
Standard operating proceduers II. - Unexpected complications with the sample shipments and the 'Standard Operating Procedures for sample packaging & shipping'
The 'Blood biomarkers' subsection of the Lancet Neurology Commission: 'Traumatic brain injury: integrated approaches to improve prevention, clinical care, and research'
Living systematic review protocols pulished in PROSPERO
Blood-Based Protein Biomarkers for the Management of Traumatic Brain Injuries in Adults Presenting to Emergency Departments with Mild Brain Injury: A Living Systematic Review and Meta-Analysis
The CENTER-TBI serum Biobank - development and current content
Protein biomarker measurements in the CENTER-TBI project (Roche/Cobas platform (S100B; NSE) and Quanterix SiMoA SR-X (GFAP, UCH-L1, NFL, Tau))
Blood biomarkers on admission in acute traumatic brain injury: Relations to severity, CT findings and care path in the CENTER-TBI study
Circulating Brain Injury Exosomal Proteins following Moderate-To-Severe Traumatic Brain Injury: Temporal Profile, Outcome Prediction and Therapy Implications
Limitations of guidelines in neurotrauma: lessons learned from recent studies
Potential role of the Young Male Syndrome in severe TBI
Long-term cognitive impairment without diffuse axonal injury following repetitive mild traumatic brain injury in rats
Biomarkers in the management of TBI across injury severities
CLOSING REMARKS
